Dn B Asset Management As Boston Scientific Corp Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

A detailed history of Dn B Asset Management As transactions in Boston Scientific Corp stock. As of the latest transaction made, Dn B Asset Management As holds 249,853 shares of BSX stock, worth $20.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
249,853
Previous 233,846 6.85%
Holding current value
$20.4 Million
Previous $16 Million 20.14%
% of portfolio
0.1%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024
BUY
$67.33 - $77.71 $1.08 Million - $1.24 Million
16,007 Added 6.85%
249,853 $19.2 Million
Q1 2024

Apr 12, 2024
SELL
$57.6 - $68.62 $15.8 Million - $18.9 Million
-274,746 Reduced 54.02%
233,846 $16 Million
Q4 2023

Jan 04, 2024
SELL
$48.64 - $57.81 $256,040 - $304,311
-5,264 Reduced 1.02%
508,592 $29.4 Million
Q3 2023

Oct 13, 2023
BUY
$50.19 - $54.68 $677,565 - $738,180
13,500 Added 2.7%
513,856 $27.1 Million
Q2 2023

Jul 06, 2023
SELL
$49.72 - $54.64 $40,869 - $44,914
-822 Reduced 0.16%
500,356 $27.1 Million
Q1 2023

Apr 20, 2023
SELL
$45.09 - $50.03 $7.54 Million - $8.36 Million
-167,114 Reduced 25.01%
501,178 $25.1 Million
Q4 2022

Jan 12, 2023
SELL
$39.56 - $47.22 $902,600 - $1.08 Million
-22,816 Reduced 3.3%
668,292 $30.9 Billion
Q3 2022

Oct 11, 2022
SELL
$36.71 - $109.66 $101,649 - $303,648
-2,769 Reduced 0.4%
691,108 $26.8 Million
Q2 2022

Jul 08, 2022
SELL
$35.24 - $47.1 $354,972 - $474,438
-10,073 Reduced 1.43%
693,877 $25.9 Billion
Q1 2022

Apr 08, 2022
SELL
$40.9 - $45.1 $2.87 Million - $3.17 Million
-70,268 Reduced 9.08%
703,950 $31.2 Million
Q4 2021

Jan 12, 2022
BUY
$38.07 - $44.87 $546,114 - $643,660
14,345 Added 1.89%
774,218 $32.9 Million
Q3 2021

Oct 15, 2021
BUY
$41.23 - $45.88 $141,707 - $157,689
3,437 Added 0.45%
759,873 $33 Million
Q2 2021

Jul 06, 2021
SELL
$38.58 - $44.24 $3.65 Million - $4.18 Million
-94,530 Reduced 11.11%
756,436 $32.3 Billion
Q1 2021

Apr 15, 2021
SELL
$35.27 - $39.67 $3.44 Million - $3.87 Million
-97,592 Reduced 10.29%
850,966 $32.9 Million
Q4 2020

Jan 19, 2021
BUY
$33.15 - $41.97 $18.6 Million - $23.6 Million
561,274 Added 144.93%
948,558 $34.1 Million
Q3 2020

Oct 14, 2020
BUY
$34.44 - $42.23 $1.13 Million - $1.39 Million
32,885 Added 9.28%
387,284 $14.8 Million
Q2 2020

Jul 08, 2020
BUY
$30.19 - $39.11 $362,823 - $470,023
12,018 Added 3.51%
354,399 $12.4 Billion
Q1 2020

Apr 17, 2020
SELL
$25.83 - $45.71 $671,967 - $1.19 Million
-26,015 Reduced 7.06%
342,381 $11.2 Million
Q4 2019

Jan 13, 2020
BUY
$37.87 - $45.37 $654,431 - $784,038
17,281 Added 4.92%
368,396 $16.7 Million
Q3 2019

Oct 16, 2019
BUY
$40.31 - $43.45 $480,293 - $517,706
11,915 Added 3.51%
351,115 $14.3 Million
Q2 2019

Jul 08, 2019
SELL
$34.91 - $42.98 $403,210 - $496,418
-11,550 Reduced 3.29%
339,200 $0
Q1 2019

Apr 11, 2019
SELL
$32.91 - $40.75 $445,338 - $551,429
-13,532 Reduced 3.71%
350,750 $0
Q4 2018

Jan 15, 2019
BUY
$31.73 - $39.04 $6.12 Million - $7.53 Million
192,752 Added 112.37%
364,282 $12.9 Million
Q3 2018

Oct 10, 2018
BUY
$32.83 - $38.63 $25,607 - $30,131
780 Added 0.46%
171,530 $0
Q2 2018

Jul 06, 2018
BUY
$26.84 - $34.32 $222,772 - $284,856
8,300 Added 5.11%
170,750 $0
Q1 2018

Apr 11, 2018
BUY
$25.2 - $28.54 $284,760 - $322,502
11,300 Added 7.48%
162,450 $0
Q4 2017

Jan 10, 2018
BUY
$24.79 - $29.8 $433,825 - $521,500
17,500 Added 13.09%
151,150 $0
Q3 2017

Oct 11, 2017
BUY
$26.26 - $29.17 $3.51 Million - $3.9 Million
133,650
133,650 $0

Others Institutions Holding BSX

# of Institutions
1,448
Shares Held
1.21B
Call Options Held
8.14M
Put Options Held
8.3M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $117B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email